Rapamycin
| Name | Rapamycin |
|---|---|
| Supplier | Biorbyt |
| Catalog | orb61092 |
| Prices | $315.00, $366.00, $383.00, $417.00, $476.00, $587.00, $995.00, $1,590.00, $2,933.00, $5,381.00 |
| Sizes | 50 mg, 100 mg, 200 mg, 250 mg, 300 mg, 500 mg, 1 g, 2 g, 5 g, 10 g |
| Cas Number | [53123-88-9] |
| Pubchem | 5284616 |
| Chemical Name | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23, |
| Formula | C51H79NO13 |
| Molecular Weight | 914.18 g/mol |
| Purity | >99% pure |
| Description | Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of -0.1 nM. A Phase II study of Rapamycin to erase angiofibromas in patients with Tuberous Sclerosis Complex (TSC) is currently ongoing. |
| Supplier Page | Shop |
